                               SEQUENCE LISTING

<110> ACCENT THERAPEUTICS, INC
 
<120> METTL3 MODULATORS

<130> 130090-00220

<140> PCT/IB2020/001135
<141> 2020-10-20

<150> 62/923,936
<151> 2019-10-21

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 11
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 1
ucuggacuaa a                                                            11


<210> 2
<211> 73
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 2
gccgagauag cucaguuggg agagcguuag acugaagauc uaaagguccc ugguucaauc       60

ccggguuucg gca                                                          73


<210> 3
<211> 39
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 3
cgauacagag aagauuagca uacgcaaauu cgugaagcg                              39


<210> 4
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Ser Gly Arg Gly Lys Gly Gly Lys Gly Leu Gly Lys Gly Gly Ala Lys 
1               5                   10                  15      


Arg His Arg Lys Val Gly Gly Lys 
            20                  


